Literature DB >> 10499670

1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA).

.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10499670

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN： 1057-5987


× No keyword cloud information.
  61 in total

1.  Tolerance and pharmacokinetic interactions of rifabutin and azithromycin.

Authors:  R Hafner; J Bethel; H C Standiford; S Follansbee; D L Cohn; R E Polk; L Mole; R Raasch; P Kumar; D Mushatt; G Drusano
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

2.  Drug Interactions with Antiretrovirals.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-06       Impact factor: 3.725

Review 3.  Antiparasitic agent atovaquone.

Authors:  Aaron L Baggish; David R Hill
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

4.  Analysis of a population-based Pneumocystis carinii pneumonia index as an outcome measure of access and quality of care for the treatment of HIV disease.

Authors:  Peter S Arno; Marc N Gourevitch; Ernest Drucker; Jing Fang; Clara Goldberg; Margaret Memmott; Karen Bonuck; Nandini Deb; Ellie Schoenbaum
Journal:  Am J Public Health       Date:  2002-03       Impact factor: 9.308

Review 5.  AIDS policy modeling for the 21st century: an overview of key issues.

Authors:  M S Rauner; M L Brandeau
Journal:  Health Care Manag Sci       Date:  2001-09

6.  Cryptococcal Meningitis in HIV-Infected Patients.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

Review 7.  Drug-Drug interactions of clinical significance in the treatment of patients with Mycobacterium avium complex disease.

Authors:  J I Kuper; M D'Aprile
Journal:  Clin Pharmacokinet       Date:  2000-09       Impact factor: 6.447

8.  Screening for hepatitis C virus in human immunodeficiency virus-infected individuals.

Authors:  C L Thio; K R Nolt; J Astemborski; D Vlahov; K E Nelson; D L Thomas
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

9.  Use of HAART among young people living with HIV.

Authors:  W Scott Comulada; Dallas T Swendeman; Mary Jane Rotheram-Borus; Kathy M Mattes; Robert E Weiss
Journal:  Am J Health Behav       Date:  2003 Jul-Aug

10.  Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America.

Authors:  Henry Masur; John T Brooks; Constance A Benson; King K Holmes; Alice K Pau; Jonathan E Kaplan
Journal:  Clin Infect Dis       Date:  2014-02-27       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.